Silver(II) Carboxylate Topical Formulations for UV Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing topical antibiotic formulations face challenges in achieving stability and efficacy, particularly with silver(II) compounds that can darken and compromise formulation integrity.
Innovation Solution
Development of silver(II) carboxylate formulations with a nominal valence of 2, dispersed in a carrier base, maintaining a standard whiteness value and controlled silver concentration, which are produced by mixing silver(II) oxide with carboxylic acid at specific temperatures and agitation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If silver(II) compounds are used in topical formulations, then antimicrobial efficacy is improved, but formulation stability deteriorates due to darkening
Solution Approach 1:
The patent changes the chemical parameter of silver by using silver(II) carboxylate compounds with specific molecular structures and oxidation states. This parameter change allows the silver to maintain antimicrobial efficacy while resisting the darkening reaction, thereby resolving the contradiction between efficacy and stability.
Solution Approach 2:
The patent creates a composite formulation by combining silver(II) carboxylate with specific carrier bases and stabilizing agents. This composite approach allows the silver compound to function effectively as an antimicrobial while the surrounding matrix prevents darkening and maintains formulation stability over time.
2Reliability
If silver concentration is increased to enhance antimicrobial action, then microbial killing effectiveness is improved, but formulation whiteness deteriorates
Solution Approach 1:
The patent changes the chemical form of silver from traditional silver salts to silver(II) carboxylates, which have intrinsic resistance to darkening. This parameter change allows the formulation to maintain high silver concentrations for enhanced antimicrobial effectiveness while preserving the desired white appearance and aesthetic properties.
3Reliability
If traditional silver compounds are used, then antimicrobial activity is achieved, but UV stability deteriorates leading to darkening
Solution Approach 1:
The patent changes the chemical structure and oxidation state parameters of silver compounds to silver(II) carboxylates. This parameter change fundamentally alters the compound's interaction with UV light, making it resistant to photo-induced darkening while maintaining full antimicrobial activity, thus resolving the contradiction between UV stability and antimicrobial effectiveness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulations exhibit antimicrobial properties while maintaining a light or white appearance, showing stability against UV exposure and selective microbial action without darkening, effectively treating skin conditions.
Implementation Method 1
mixing the carboxylic acid and the silver(II) oxide to produce a reaction mixture; and heating the reaction mixture to produce an aliphatic silver carboxylate
Implementation Method 2
the at least one silver-containing compound being dispersed within the base; the at least one silver-containing compound being intimately dispersed within the base
Implementation Method 3
showing stability against UV exposure and selective microbial action without darkening
Data Source
Figure 1
Figure 2~7
Figure 3
AI summary
The present invention relates to antibiotic formulations and methods, and more particularly, to topical silver(II) antibiotic formulations, methods of production thereof, and methods of use thereof.